Financhill
Buy
64

ULTA Quote, Financials, Valuation and Earnings

Last price:
$601.07
Seasonality move :
0.51%
Day range:
$575.00 - $611.90
52-week range:
$309.01 - $611.90
Dividend yield:
0%
P/E ratio:
23.05x
P/S ratio:
2.38x
P/B ratio:
10.36x
Volume:
3.4M
Avg. volume:
674.4K
1-year change:
53.1%
Market cap:
$27B
Revenue:
$11.3B
EPS (TTM):
$26.09

Earnings Data

Next earnings date for ULTA
Mar 12
2026
Most recent earnings per share
$5.14
Beat by $0.53
(Dec 4/2025)
Consensus Estimate
$4.61
(Dec 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ULTA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2026 Q1 $3.8B -- -- $7.88 --
12/04/2025 Q4 $2.7B $2.9B $5.14 $4.61 $0.53
08/28/2025 Q3 $2.7B $2.8B $5.78 $5.10 $0.68
05/29/2025 Q2 $2.8B $2.8B $6.70 $5.83 $0.87
03/13/2025 Q1 $3.5B $3.5B $8.46 $7.14 $1.32
12/05/2024 Q4 $2.5B $2.5B $5.14 $4.53 $0.61
08/29/2024 Q3 $2.6B $2.6B $5.30 $5.47 -$0.17
05/30/2024 Q2 $2.7B $2.7B $6.47 $6.28 $0.19
03/14/2024 Q1 $3.5B $3.6B $8.08 $7.54 $0.55
11/30/2023 Q4 $2.5B $2.5B $5.07 $4.97 $0.09
08/24/2023 Q3 -- $2.5B $6.02 -- --
05/25/2023 Q2 -- $2.6B $6.88 -- --
03/09/2023 Q1 -- $3.2B $6.68 -- --
12/01/2022 Q4 -- $2.3B $5.34 -- --
08/25/2022 Q3 -- $2.3B $5.70 -- --
05/26/2022 Q2 -- $2.3B $6.30 -- --
03/10/2022 Q1 -- $2.7B $5.41 -- --
12/02/2021 Q4 -- $2B $3.94 -- --
08/25/2021 Q3 -- $2B $4.56 -- --
05/27/2021 Q2 -- $1.9B $4.10 -- --
03/11/2021 Q1 -- $2.2B $3.03 -- --
12/03/2020 Q4 -- $1.6B $1.32 -- --
08/27/2020 Q3 -- $1.2B $0.14 -- --
05/28/2020 Q2 -- $1.2B -$1.39 -- --
03/12/2020 Q1 -- $2.3B $3.89 -- --
12/05/2019 Q4 -- $1.7B $2.25 -- --
08/30/2019 Q3 -- $1.7B $2.76 -- --
05/30/2019 Q2 -- $1.7B $3.26 -- --
03/14/2019 Q1 -- $2.1B $3.61 -- --
12/06/2018 Q4 -- $1.6B $2.18 -- --
08/30/2018 Q3 -- $1.5B $2.46 -- --
05/31/2018 Q2 -- $1.5B $2.70 -- --
03/15/2018 Q1 -- $1.9B $3.40 -- --
11/30/2017 Q4 -- $1.3B $1.70 -- --
08/24/2017 Q3 -- $1.3B $1.83 -- --
05/25/2017 Q2 -- $1.3B $2.05 -- --
03/09/2017 Q1 -- $1.6B $2.24 -- --
12/01/2016 Q4 -- $1.1B $1.40 -- --
08/25/2016 Q3 -- $1.1B $1.43 -- --
05/26/2016 Q2 -- $1.1B $1.45 -- --
03/10/2016 Q1 -- $1.3B $1.69 -- --

Ulta Beauty, Inc. Earnings Questions

  • How Much did Ulta Beauty, Inc. Generate in Revenue Last Quarter?

    Ulta Beauty, Inc. reported $2.9B worth of top line sales in its most recent quarter.

  • Did Ulta Beauty, Inc. Beat Earnings Last Quarter?

    Ulta Beauty, Inc. announced earnings per share of $5.14 which represents a beat of analyst forecast a $4.61 per share.

  • Is Ulta Beauty, Inc. Profitable?

    Ulta Beauty, Inc. reported $1.2B that represents $25.74 per share over the last quarter.

  • What is the Analyst Consensus for Ulta Beauty, Inc. EPS Next Year?

    Ulta Beauty, Inc.'s earnings are forecast to decrease from $25.34 per share to $24.02 per share next year representing a decrease of -3.23%.

  • When is Ulta Beauty, Inc.'s Earnings Date?

    Ulta Beauty, Inc.'s next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock